KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,692,793 | +2518.0% | 212,596 | +1521.8% | 0.00% | – |
| Q1 2023 | $141,053 | -95.6% | 13,109 | -93.9% | 0.00% | -100.0% |
| Q4 2022 | $3,199,099 | +1697.2% | 213,558 | +1441.4% | 0.00% | – |
| Q3 2022 | $178,000 | +50.8% | 13,855 | +13.3% | 0.00% | – |
| Q2 2022 | $118,000 | +4.4% | 12,233 | +7.3% | 0.00% | – |
| Q1 2022 | $113,000 | -15.0% | 11,396 | +1.4% | 0.00% | – |
| Q4 2021 | $133,000 | -8.3% | 11,240 | -11.7% | 0.00% | – |
| Q3 2021 | $145,000 | -5.2% | 12,736 | +15.9% | 0.00% | – |
| Q2 2021 | $153,000 | -88.0% | 10,985 | -78.1% | 0.00% | – |
| Q2 2020 | $1,276,000 | +2.4% | 50,074 | +12.9% | 0.00% | – |
| Q4 2018 | $1,246,000 | – | 44,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |